Kevin Walter Collins - 27 May 2022 Form 4 Insider Report for Lucira Health, Inc.

Role
Chief Revenue Officer
Signature
/s/ Dan George, Attorney-in-Fact for Kevin W. Collins
Issuer symbol
N/A
Transactions as of
27 May 2022
Net transactions value
-$74,218
Form type
4
Filing time
12 Jul 2022, 18:24:07 UTC
Previous filing
30 Jun 2021
Next filing
29 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LHDXQ Common Stock Sale $74,218 -37,109 -9.2% $2.00* 364,968 27 May 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 18, 2021 for 396,975 shares.
F2 Includes 5,102 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on February 20, 2022.